These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28899617)

  • 1. Better medicines for neonates: Improving medicine development, testing, and prescribing.
    Allegaert K
    Early Hum Dev; 2017 Nov; 114():22-25. PubMed ID: 28899617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal drug therapy: The first frontier of therapeutics for children.
    Allegaert K; van den Anker J
    Clin Pharmacol Ther; 2015 Sep; 98(3):288-97. PubMed ID: 26095519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology in neonates: small size, huge variability.
    Allegaert K; van den Anker JN
    Neonatology; 2014; 105(4):344-9. PubMed ID: 24931327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach.
    Allegaert K; Cosaert K; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5674-9. PubMed ID: 26323412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug evaluation studies in neonates: how to overcome the current limitations.
    Allegaert K; Smits A; van den Anker JN
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):387-396. PubMed ID: 29421929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on medication use in the neonatal intensive care unit.
    Allegaert K; Simons S; Van Den Anker J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):343-353. PubMed ID: 30741041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical research in neonates and infants: Challenges and perspectives.
    Coppini R; Simons SHP; Mugelli A; Allegaert K
    Pharmacol Res; 2016 Jun; 108():80-87. PubMed ID: 27142783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in neonatal pharmacotherapy.
    Calhoun DA; Murthy SN; Bryant BG; Luedtke SA; Bhatt-Mehta V
    Ann Pharmacother; 2006 Apr; 40(4):710-9. PubMed ID: 16569801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.
    Jacqz-Aigrain E
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S27-30. PubMed ID: 21269785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials in neonates: a therapeutic imperative.
    Ward RM; Kern SE
    Clin Pharmacol Ther; 2009 Dec; 86(6):585-7. PubMed ID: 19915600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From immature pharmacotherapy towards pharmacotherapy of the immature.
    Allegaert K; van den Anker JN
    Semin Fetal Neonatal Med; 2022 Apr; 27(2):101327. PubMed ID: 35393255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment.
    Allegaert K; van den Anker J
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S152-S160. PubMed ID: 34185907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of biomarkers in human pharmacology (Phase I) studies.
    Cohen AF; Burggraaf J; van Gerven JM; Moerland M; Groeneveld GJ
    Annu Rev Pharmacol Toxicol; 2015; 55():55-74. PubMed ID: 25292425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and lessons learned in Neonatal Drug Therapies.
    Aranda JV
    Semin Perinatol; 2016 Apr; 40(3):137. PubMed ID: 26791054
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation for neonatal emergencies: a neonatal emergency medication sheet.
    Fonner CJ; Rushton CH; Fletcher AB
    Pediatr Nurs; 1989; 15(5):527-30. PubMed ID: 2587112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.
    Vinks AA; Emoto C; Fukuda T
    Clin Pharmacol Ther; 2015 Sep; 98(3):298-308. PubMed ID: 26073179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal pharmacology--pharmacokinetics.
    Johnson PJ
    Neonatal Netw; 2011 Jan-Feb 1; 30(1):54-61. PubMed ID: 21317099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision therapeutics in the NICU: why are we missing the mark?
    Lewis T
    J Perinatol; 2018 May; 38(5):444-446. PubMed ID: 29379159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.